AffRegion.i
Exploration
Accueil
Racine
Exploration
Accueil
Racine

Serveur d'exploration Tocilizumab - Exploration (Accueil)

Index « AffRegion.i » - entrée « Occitanie (région administrative) »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Nouvelle-Galles du Sud < Occitanie (région administrative) < Ohio  Facettes :

List of bibliographic references indexed by Occitanie (région administrative)

Number of relevant bibliographic references: 100.
[40-60] [0 - 20][0 - 50][60-80]
Ident.Authors (with country if any)Title
002037 (2015) Francisco Espinoza [France] ; Christian Jorgensen [France] ; Yves-Marie Pers [France]Efficacy of Tocilizumab in the treatment of Eosinophilic fasciitis: Report of one case.
002040 (2015) Yves-Marie Pers [France] ; Roxane Schaub [France] ; Elodie Constant [France] ; Joseph Lambert [France] ; Marie Godfrin-Valnet [France] ; Clémentine Fortunet [France] ; Waafa Bourichi [France] ; Béatrice Pallot Prades [France] ; Daniel Wendling [France] ; Philippe Gaudin [France] ; Christian Jorgensen [France] ; Jean-Francis Maillefert [France] ; Hubert Marotte [France]Efficacy and safety of tocilizumab in elderly patients with rheumatoid arthritis.
002067 (2015) Ciara L. Freeman [Royaume-Uni] ; Franck Morschhauser [France] ; Laurie Sehn [Canada] ; Mark Dixon [Royaume-Uni] ; Richard Houghton [Royaume-Uni] ; Thierry Lamy [France] ; Günter Fingerle-Rowson [Suisse] ; Elisabeth Wassner-Fritsch [Suisse] ; John G. Gribben [Royaume-Uni] ; Michael Hallek [Allemagne] ; Gilles Salles [France] ; Guillaume Cartron [France]Cytokine release in patients with CLL treated with obinutuzumab and possible relationship with infusion-related reactions
002371 (2014) Yves-Marie Pers [France] ; Clémentine Fortunet ; Elodie Constant ; Joseph Lambert ; Marie Godfrin-Valnet ; Audrey De Jong ; Grégoire Mercier ; Béatrice Pallot Prades ; Daniel Wendling ; Philippe Gaudin ; Christian Jorgensen ; Hubert Marotte ; Jean-Francis MaillefertPredictors of response and remission in a large cohort of rheumatoid arthritis patients treated with tocilizumab in clinical practice.
002372 (2014) Claire I. Daïen [France] ; Jacques Morel [France]Predictive Factors of Response to Biological Disease Modifying Antirheumatic Drugs: Towards Personalized Medicine
002428 (2014) Karen Delavigne [France] ; Emilie Bérard [France] ; Sarah Bertoli [France] ; Jill Corre [France] ; Eliane Duchayne [France] ; Cécile Demur [France] ; Véronique Mansat-De Mas [France] ; Cécile Borel [France] ; Muriel Picard [France] ; Muriel Alvarez [France] ; Audrey Sarry [France] ; Françoise Huguet [France] ; Christian Récher [France]Hemophagocytic syndrome in patients with acute myeloid leukemia undergoing intensive chemotherapy
002643 (2013) L. Sailler [France] ; G. Pugnet ; B. Bienvenu[Treatment of giant cell arteritis].
002836 (2013) Nienke Ter Haar [Pays-Bas] ; Helen Lachmann [Royaume-Uni] ; Seza Özen [Turquie] ; Pat Woo [Royaume-Uni] ; Yosef Uziel [Israël] ; Consuelo Modesto [Espagne] ; Isabelle Koné-Paut [France] ; Luca Cantarini [Italie] ; Antonella Insalaco [Italie] ; Bénédicte Neven [France] ; Michael Hofer [Suisse] ; Donato Rigante [Italie] ; Sulaiman Al-Mayouf [Arabie saoudite] ; Isabelle Touitou [France] ; Romina Gallizzi [Italie] ; Efimia Papadopoulou-Alataki [Grèce] ; Silvana Martino [Italie] ; Jasmin Kuemmerle-Deschner [Allemagne] ; Laura Obici [Italie] ; Nicolae Iagaru [Roumanie] ; Anna Simon [Pays-Bas] ; Susan Nielsen [Danemark] ; Alberto Martini [Italie] ; Nicolino Ruperto [Italie] ; Marco Gattorno [Italie] ; Joost Frenkel [Pays-Bas]Treatment of autoinflammatory diseases: results from the Eurofever Registry and a literature review
002851 (2013) Bernard Combe [France] ; Ronald Van Vollenhoven [Suède]Novel targeted therapies: the future of rheumatoid arthritis? Mavrilumab and tabalumab as examples
002852 (2013) Jessy Présumey [France] ; Gabriel Courties [France] ; Pascale Louis-Plence [France] ; Virginie Escriou [France] ; Daniel Scherman [France] ; Yves-Marie Pers [France] ; Hans Yssel [France] ; Jérôme Pène [France] ; Diego Kyburz [Suisse] ; Steffen Gay [Suisse] ; Christian Jorgensen [France] ; Florence Apparailly [France]Nicotinamide phosphoribosyltransferase/visfatin expression by inflammatory monocytes mediates arthritis pathogenesis
002874 (2013) Josef S. Smolen [Autriche] ; Monika M. Schoels [Autriche] ; Norihiro Nishimoto [Japon] ; Ferdinand C. Breedveld [Pays-Bas] ; Gerd R. Burmester [Allemagne] ; Maxime Dougados [France] ; Paul Emery [Royaume-Uni] ; Gianfranco Ferraccioli [Italie] ; Cem Gabay [Suisse] ; Allan Gibofsky [États-Unis] ; Juan Jesus Gomez-Reino [Espagne] ; Graeme Jones [Australie] ; Tore K. Kvien [Norvège] ; Miho Murakami [Japon] ; Neil Betteridge [Royaume-Uni] ; Clifton O. Bingham [États-Unis] ; Vivian Bykerk [Suisse] ; Ernest H. Choy [Royaume-Uni] ; Bernard Combe [France] ; Maurizio Cutolo [Italie] ; Winfried Graninger [Autriche] ; Angel Lanas [Espagne] ; Emilio Martin-Mola [Espagne] ; Carlomaurizio Montecucco [Italie] ; Mikkel Ostergaard [Danemark] ; Karel Pavelka [République tchèque] ; Andrea Rubbert-Roth [Allemagne] ; Naveed Sattar [Royaume-Uni] ; Marieke Scholte-Voshaar [Suisse] ; Yoshiya Tanaka [Japon] ; Michael Trauner [Autriche] ; Gabriele Valentini [Italie] ; Kevin L. Winthrop [États-Unis] ; Maarten De Wit [Pays-Bas] ; Désirée Van Der Heijde [Pays-Bas]Consensus statement on blocking the effects of interleukin-6 and in particular by interleukin-6 receptor inhibition in rheumatoid arthritis and other inflammatory conditions
002882 (2013) Guillaume Moulis [France] ; Grégory Pugnet [France] ; Laurent Sailler [France] ; Leonardo Astudillo [France] ; Philippe Arlet [France]Abatacept in relapsing polychondritis
002A05 (2013) A. Frazier-Mironer [France] ; A. Cantagrel [France] ; B. Combe [France] ; V. Deschamps ; M. Dougados [France] ; R.-M. Flipo ; I. Logeart ; X. Mariette ; T. Schaeverbeke ; J. Sibilia [France] ; X. Le Loët [France]THU0173 Retention Rates of Adalimumab, Etanercept and Infliximab as First and Second-Line Biologic Therapy in Patients with Rheumatoid Arthritis in Daily Practice: The Maintain Study
002A07 (2013) I. Castrej N [États-Unis] ; M. Dougados [France] ; B. Combe [France] ; F. Guillemin [France] ; B. Fautrel [France] ; T. Pincus [États-Unis]THU0165 Predictive Value of Different Remission Criteria for a Good Functional Status Outcome: Results from the Espoir Cohort
002A25 (2013) Y.-M. Pers [France] ; C. Fortunet ; E. Constant ; J. Lambert [France] ; A. Mazouyes [France] ; M. Valnet [France] ; H. Marotte ; P. Gaudin [France] ; D. Wendling [France] ; J.-F. Maillefert ; C. Jorgensen [France]THU0126 Multicenter retrospective study: Response to tocilizumab in clinical practice is not influenced by the number of previous biotherapy or by association with a DMARD
002A30 (2013) S. Godot [France] ; J. E. Gottenberg [France] ; S. Paternotte ; I. Pane [France] ; B. Combe [France] ; J. Sibilia [France] ; R.-M. Flipo ; T. Schaeverbeke ; P. Ravaud [France] ; E. Toussirot ; F. Berenbaum [France] ; X. Mariette [France] ; D. Wendling ; J. Sellam [France]THU0122 Safety of surgery in patients with rheumatoid arthritis treated by rituximab in routine care: Data from the french air registry
002A50 (2013) L. Gossec [France] ; S. Rouanet ; G. Steinberg ; B. Combe [France]THU0063 Does biologic treatment modify the relationship of the variables associated with fatigue in patients with rheumatoid arthritis? The peps study of tocilizumab in real life
002B72 (2013) A. Saraux ; S. Rouanet ; R.-M. Flipo ; J.-C. Poncet ; P. Fardellone ; C. Contré [France] ; A. Cantagrel [France]SAT0111 Description of Glucocorticoid Sparing Effect in Rheumatoid Arthritis (RA) Patients Treated by Tocilizumab (TCZ) in Real Life: An Interim Analysis of the Spare-1 Study
002B74 (2013) G. R. Burmester [Allemagne] ; A. Rubbert-Roth [Allemagne] ; A. Cantagrel [France] ; S. Hall [Australie] ; P. Leszczynski [Pologne] ; D. Feldman [Brésil] ; M. J. Rangaraj ; G. Roane ; C. Ludivico [États-Unis] ; E. Mysler [Argentine] ; L. Rowell [Royaume-Uni] ; I. Vranic [Royaume-Uni]SAT0105 Summacta: A Randomized, Double-Blind, Parallel Group Study of the Safety and Efficacy Of Tocilizumab SC Versus Tocilizumab IV, in Combination with Traditional Dmards in Patients With Moderate to Severe Ra
002C08 (2013) T. Krams ; A. Ruyssen-Wtrand [France] ; D. Nigon ; B. Fautrel ; F. Berenbaum [France] ; A. Cantagrel ; A. Constantin [France]SAT0022 In Rheumatoid Arthritis, Younger Age at Onset is Associated with a Higher Rate of Remission at 1 Year: Results from a French Cohort of Early Arthritis Patients (Espoir Cohort)
002C33 (2013) Alessandra Blaizot [France] ; Paul Monsarrat [France] ; Arnaud Constantin [France] ; Jean-Noel Vergnes [France] ; Gabriel Fernandez De Grado [France] ; Cathy Nabet [France] ; Alain Cantagrel [France] ; Michel Sixou [France]Oral health‐related quality of life among outpatients with rheumatoid arthritis

List of associated Author.i

Nombre de
documents		Descripteur
17Bernard Combe
14Yves-Marie Pers
12B. Combe
12Christian Jorgensen
12Jacques Morel
10Xavier Mariette
9A. Cantagrel
9Maxime Dougados
9X. Mariette
8Jacques-Eric Gottenberg
8M. Dougados
8T. Schaeverbeke
7Paul Emery
6Guillaume Moulis
6J. Sibilia
6Jean Sibilia
6Josef S. Smolen
6Pascale Louis-Plence
5Arnaud Constantin
5Daniel Aletaha
5Daniel Wendling
5Désirée Van Der Heijde
5Laurent Sailler
5Maarten De Wit
5Maurizio Cutolo
5Philippe Ravaud
5Pierre Portales
5Sylvie Fabre
5X. Le Loët
4Alain Cantagrel
4Alain Saraux
4Andrea Rubbert-Roth
4Claire Daien
4Emilio Martin-Mola
4Gerd Burmester
4Grégory Pugnet
4Jean-François Eliaou
4Julie Quentin
4Laure Gossec
4Olivier Vittecoq
4P. Ravaud
4Philippe Arlet
4R.-M. Flipo
4Ronald Van Vollenhoven
4S. Rouanet
4Tore K. Kvien
3A. Constantin
3A. Saraux
3Adeline Ruyssen-Witrand
3B. Fautrel
3Cem Gabay
3Cécile Gaujoux-Viala
3Cédric Lukas
3D. Wendling
3E. Hachulla
3Elisabeth Solau-Gervais
3Ferdinand C. Breedveld
3Gerd R. Burmester
3Hubert Marotte
3I. Pane
3Iain Mcinnes
3Isabelle Koné-Paut
3Jean-Francis Maillefert
3Jean-François Rossi
3Juan Gomez-Reino
3Karel Pavelka
3Leonardo Astudillo
3Maarten Boers
3Michael Hofer
3P. Emery
3Pascal Pillet
3Philippe Gaudin
3Robert Landewé
3T. Bardin
3Valérie Devauchelle-Pensec
2
2A. Rubbert-Roth
2A. Ruyssen-Witrand
2Alberto Martini
2Aleth Perdriger
2Alexander Foss
2Alexandre Belot
2Amy Chadburn
2Angela Dispenzieri
2Angela Zink
2Anna Simon
2Anne Lohse
2Antonella Insalaco
2Augustin Le Naour
2Axel Finckh
2Aymeric Binard
2B. Bienvenu
2Bettina Couderc
2Brigitte Bader-Meunier
2Béatrice Pallot Prades
2Bénédicte Neven
2C. Jorgensen
2C. Lukas
2C. Miceli-Richard
2Carine Wouters

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/Main/Exploration

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/AffRegion.i -k "Occitanie (région administrative)" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/AffRegion.i  \
                -Sk "Occitanie (région administrative)" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    TocilizumabV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    AffRegion.i
   |clé=    Occitanie (région administrative)
}}
Wicri

This area was generated with Dilib version V0.6.34.
Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021